CA2246754A1 - Vecteurs d'apport de structures cochleaires - Google Patents
Vecteurs d'apport de structures cochleairesInfo
- Publication number
- CA2246754A1 CA2246754A1 CA002246754A CA2246754A CA2246754A1 CA 2246754 A1 CA2246754 A1 CA 2246754A1 CA 002246754 A CA002246754 A CA 002246754A CA 2246754 A CA2246754 A CA 2246754A CA 2246754 A1 CA2246754 A1 CA 2246754A1
- Authority
- CA
- Canada
- Prior art keywords
- cochleate
- delivery vehicles
- component
- biologically relevant
- cochleate delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18834—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
WOPCT/US96/01704 | 1996-02-22 | ||
PCT/US1996/001704 WO1996025942A1 (fr) | 1995-02-22 | 1996-02-22 | Phospholipides cochleaires utilises dans l'administration de medicaments |
PCT/US1997/002632 WO1997030725A1 (fr) | 1996-02-22 | 1997-02-21 | Vecteurs d'apport de structures cochleaires |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2246754A1 true CA2246754A1 (fr) | 1997-08-28 |
CA2246754C CA2246754C (fr) | 2002-10-22 |
Family
ID=22254697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002246754A Expired - Fee Related CA2246754C (fr) | 1996-02-22 | 1997-02-21 | Vecteurs d'apport de structures cochleaires |
Country Status (2)
Country | Link |
---|---|
CA (1) | CA2246754C (fr) |
WO (1) | WO1997030725A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9810051D0 (en) * | 1998-05-11 | 1998-07-08 | Nycomed Imaging As | Contrast media |
US6340591B1 (en) * | 1998-12-14 | 2002-01-22 | University Of Maryland | Integrative protein-DNA cochleate formulations and methods for transforming cells |
US6153217A (en) * | 1999-01-22 | 2000-11-28 | Biodelivery Sciences, Inc. | Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents |
AU2007200813B2 (en) * | 1999-01-22 | 2010-06-03 | Biodelivery Sicencies, Inc. | Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
JP2003529557A (ja) * | 2000-01-24 | 2003-10-07 | バイオデリバリー サイエンス インコーポレーテッド | コクリエート製剤、その調製方法および生物学的関連分子投与のための用途 |
US20040146551A1 (en) | 2002-11-01 | 2004-07-29 | Biodelivery Sciences International, Inc. | Geodate delivery vehicles |
US20050008686A1 (en) * | 2003-01-15 | 2005-01-13 | Mannino Raphael J. | Cochleate preparations of fragile nutrients |
WO2004091578A2 (fr) | 2003-04-09 | 2004-10-28 | Biodelivery Sciences International, Inc. | Procedes de formation de structures cochleaires, structures cochleaires, et procedes d'utilisation |
WO2004091572A2 (fr) * | 2003-04-09 | 2004-10-28 | Biodelivery Sciences International, Inc. | Compositions contenant des structures cochleaires, dirigees contre l'expression de proteines |
EP1674093A4 (fr) * | 2003-10-15 | 2009-12-09 | Nanoegg Res Lab Inc | Procede de controle de la taille particulaire de nanoparticules d'acide retinoique revetues d'un sel inorganique metallique polyvalent et nanoparticules obtenues par ledit procede |
AU2003273010A1 (en) * | 2003-10-15 | 2005-05-05 | Ltt Bio-Pharma Co., Ltd. | Composition containing retinoic acid nanoparticles coated with polyvalent metal inorganic salt |
WO2011016043A2 (fr) | 2009-08-06 | 2011-02-10 | Technion Research & Development Foundation Ltd. | Libération de médicament antibiotique et potentialisation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4078052A (en) * | 1976-06-30 | 1978-03-07 | The United States Of America As Represented By The Secretary Of Health, Education And Welfare | Large unilamellar vesicles (LUV) and method of preparing same |
US4725442A (en) * | 1983-06-17 | 1988-02-16 | Haynes Duncan H | Microdroplets of water-insoluble drugs and injectable formulations containing same |
US4874795A (en) * | 1985-04-02 | 1989-10-17 | Yesair David W | Composition for delivery of orally administered drugs and other substances |
US4871488A (en) * | 1985-04-22 | 1989-10-03 | Albany Medical College Of Union University | Reconstituting viral glycoproteins into large phospholipid vesicles |
US4663161A (en) * | 1985-04-22 | 1987-05-05 | Mannino Raphael J | Liposome methods and compositions |
US4906476A (en) * | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
US5571517A (en) * | 1990-08-13 | 1996-11-05 | Yesair; David W. | Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories |
-
1997
- 1997-02-21 WO PCT/US1997/002632 patent/WO1997030725A1/fr active Search and Examination
- 1997-02-21 CA CA002246754A patent/CA2246754C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2246754C (fr) | 2002-10-22 |
WO1997030725A1 (fr) | 1997-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2212382A1 (fr) | Substances cochleaires utilisees comme excipients | |
CA2246754A1 (fr) | Vecteurs d'apport de structures cochleaires | |
AU570875B1 (en) | Multi-system heat pump air-conditioner with single outdoor unit. | |
GB2225065B (en) | Improvements in or relating to pumping devices. | |
CA2279270A1 (fr) | Polyesteramides renfermant des groupes derives amino-acides alternant avec des groupes derives alpha-hydroxyacides et pieces moulees fabriquees a partir de ces polyesteramides | |
EP0631366A3 (fr) | Pompe à entraînement magnétique avec un élément de palier de butée arrière. | |
CA2198195A1 (fr) | Contenant avec composantes lyophilisees de vaccin | |
CA2332915A1 (fr) | Compositions renfermant des analogues d'acide gamma-aminobutyrique (gaba) et de la cafeine | |
AU5272693A (en) | Greeting card with compatible puzzle message | |
CA2386817A1 (fr) | Utilisation du baclofene pour traiter le syndrome du sevrage de l'alcool et pour favoriser l'abstinence chez les alcooliques | |
EP0827749A3 (fr) | Solution pour dialyse péritonéale | |
IT9048350A0 (it) | Complesso di accostamento per cuscinetto di spinta di innesto, in particolare per autoveicolo. | |
ZA977327B (en) | Pharmaceutical composition containing 4-oxobutanoic acids. | |
AU6285390A (en) | Improvements in or relating to i.c. engines | |
HUT52847A (en) | Compressor unit with propeller pump or similar device | |
CA2180867A1 (fr) | Diols monomeres et oligomeres a liaison phosphate formes a partir de ces derniers | |
ZA971841B (en) | Polyaspartic acid and its analogues in combination with insecticides. | |
IE872589L (en) | Treated lipid regulator | |
AU2916684A (en) | Polyamide compositions, use in contact with antifreeze | |
AU3787797A (en) | Drinkable, acid nutrient composition with long shelf life and health-promoting action | |
AU636695B2 (en) | Display unit, in particular for motor vehicles | |
AU7425894A (en) | Improvements in or relating to liquid extraction | |
McGrath | Postsecondary participation in Newfoundland | |
CA2233751A1 (fr) | Tableau d'affichage ameliore et methode pour reduire l'inventaire de tableaux d'affichage | |
AU3229697A (en) | Improved blood contact surfaces using extracellular matrix synthesized (in vitro) having bioactive species immobilized thereto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20130221 |